TNFA - TNF Pharma Market Cap to Sales Volume

Brandmark of TNF Pharmaceuticals (TNFA)

The TNF Pharmaceuticals targeted therapy ecosystem, based on the study of tumor necrosis factor, defines the current trend, where the company's price/sales multiple confirms its market valuation. The indicator expresses the state of the metric during the waiting period for new clinical test results. Unique patents and strict FDA control serve as a defensive asset, creating high barriers to entry for competitors.

TNFA (tnfpharma.com) P/S Multiple history from 07/04/2022 to 11/13/2026

Metric breakdowns and analytics for TNF Pharmaceuticals (TNFA)

- share price and consensus valuation forecast:
Price Performance Chart tnfpharma.com|TNFA - Consensus Target
- market capitalization statistics:
Market Value TNF Pharma|TNFA - Total Company Value
- book capitalization information:
Equity per Share TNF Pharmaceuticals|TNFA - Book Capitalization|Market Capitalization to Net Assets tnfpharma.com|TNFA - Cumulative Company Assets
- issuer credit burden and liquidity indicators:
All Debt to Shareholders' Equity Ratio TNF Pharmaceuticals|TNFA - Long-Term Debt to Equity|Current Liabilities to Equity tnfpharma.com|TNFA - Company Aggregate Debts|Debt to Net Assets Ratio TNF Pharma|TNFA - Company Long-Term Debts|Company Short-Term Debts TNF Pharmaceuticals|Intermediate Coverage Ratio tnfpharma.com
- net income and valuation multiples indicators:
TNFA - Company Net Income|Future Profit TNF Pharmaceuticals|TNFA - P/E Multiple|Forward P/E Multiple tnfpharma.com|TNFA - PEG Multiple|Enterprise Value to EBITDA Ratio TNF Pharma|TNFA - Operating profit EBITDA|Net earnings per one share for the last twelve months TNF Pharmaceuticals|TNFA - Net earnings per share for the last 12 months|Quarterly EPS earnings growth tnfpharma.com|TNFA - Net earnings per share growth this year|Projected earnings per share increase next year TNF Pharmaceuticals
- issuer revenue and sales details:
TNFA - Revenue and Sales Volume|Company Future Sales tnfpharma.com|TNFA - P/S Multiple|Forward Price-to-Revenue Multiple TNF Pharma
General company analysis:TNF Pharmaceuticals Inc., TNFA
Finished products of TNF Pharmaceuticals

The P/S multiple determines the market value of TNF Pharmaceuticals (TNFA) relative to its annual revenue, allowing for an assessment of asset monetization efficiency without considering operating expenses. Investments in the environmental modernization of plants and closed-loop water consumption systems may temporarily impact margins; therefore, the price-to-sales multiple serves as a key indicator of the business's fundamental overvaluation during periods of technological upgrading.

Competing companies

HLN (haleon.com) - Market Capitalization-to-Revenue Ratio|Kenvue - Market Cap to Revenue|Market Cap to Sales Volume VRNA (Verona Pharma PLC)|MENS - Price-to-Revenue Ratio|LGND (Ligand Corp) - Market Cap to Revenue Ratio|AMRX: P/S Multiple|Price-to-Sales Ratio PRGO (perrigo.com)|Market Cap to Revenue ALVO|LQDA: Market Capitalization-to-Revenue Ratio|Price-to-Revenue Ratio Galapagos Genomics (GLPG)|ANIP: Price-to-Sales Ratio|P/S Multiple MNKD (MannKind Corporation)|Market Capitalization-to-Revenue Ratio AMPH|Pacira BioSciences, Inc. - P/S Multiple|SPRY - P/S Multiple|Theravance (TBPH) - Price-to-Revenue Ratio|Aquestive Corp - Market Capitalization-to-Revenue Ratio|Price-to-Revenue Ratio scPharmaceuticals, Inc.|Market Cap to Revenue Tectonic (TECX)|P/S Multiple TNXP|P/S Multiple sxtchina.com (SXTC)|P/S Multiple EPRX (Eupraxia Pharmaceuticals Inc.)|BHST - Market Cap to Revenue|eXoZymes Inc - P/S Multiple|Price to Sales Oramed Pharmaceuticals|ENTX (enterabio.com) - Market Cap to Revenue|MindWalk Holdings, Inc. (HYFT) - P/S Multiple|Market Cap to Revenue ABVC|CPIX (Cumberland Corp) - Market Cap to Sales Volume|P/S Multiple QNTM|Price-to-Revenue Coefficient fibrogen.com|P/S Multiple TELO (Telomir Pharmaceuticals, Inc.)|RANI - Market Cap to Revenue|Synergy CHC Corporation - P/S Multiple|RLYB - P/S Multiple|lexariabioscience.com (LEXX) - Price-to-Revenue Ratio|PULM (pulmatrix.com) - Price-to-Revenue Ratio|Price-to-Revenue Ratio Pheton Holdings Limited|Aptorum (APM) - Price-to-Revenue Coefficient|Market Cap to Revenue LYRA (Lyra Therapeutics, Inc)|Market Cap to Sales Volume IBO|Price-to-Revenue Ratio cbdMD YCBD|PRFX: Market Cap to Revenue Ratio|Auris Medical - P/S Multiple|Price-to-Sales Ratio LIPO|OPTN: P/S Multiple|Pieris Pharma (PIRS) - P/S Multiple|Price-to-Revenue Ratio Procaps Group S.A.|petrospharma.com - Price-to-Sales Ratio|P/S Multiple QLI|SLRN (Acelyrin Inc.) - Market Capitalization-to-Revenue Ratio|P/S Multiple TFFP (TFF Pharma)